Achievement of red blood cell transfusion independence in red blood cell transfusion-dependent patients with lower-risk non-del(5q) myelodysplastic syndromes correlates with serum erythropoietin levels-Reference-Cited by-同舟云学术

Achievement of red blood cell transfusion independence in red blood cell transfusion-dependent patients with lower-risk non-del(5q) myelodysplastic syndromes correlates with serum erythropoietin levels

Published:2020-02-17 Issue:6 Volume:61 Page:1475-1483
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Santini Valeria¹,Almeida Antonio²,Giagounidis Aristoteles³,Skikne Barry⁴,Beach CL⁴,Weaver Jerry⁴,Tu Nora⁵,Fenaux Pierre⁶

Affiliation:

1. MDS Unit, Hematology, AOU Careggi, University of Florence, Florence, Italy;

2. Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal;

3. Marien Hospital Düsseldorf, Düsseldorf, Germany;

4. Celgene Corporation, Summit, NJ, USA;

5. Formerly Celgene Corporation, Summit, NJ, USA;

6. Service d’Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1719088

Reference34 articles.

1. Myelodysplastic syndromes

2. International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes

3. Revised International Prognostic Scoring System for Myelodysplastic Syndromes

4. Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)

5. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in myelodysplastic syndromes: promising novel agents and combination strategies;Expert Review of Hematology;2023-01-02

2. Myelodysplastic Syndromes and Metabolism;International Journal of Molecular Sciences;2021-10-19

3. Efficacy of lenalidomide in a patient with systemic mastocytosis associated with SF3B1-mutant myelodysplastic syndrome;Leukemia & Lymphoma;2021-06-21